Findings based on the TCGA cohort suggested considerable enrichment of cancer-associated pathways in subtypes C1 and C2, such as glycolysis, PI3K-AKT-mTOR, angiogenesis, hypoxia, P53, and apoptosis (Figure 2A). This evidence concerns the gene MTOR and cancer.